Susceptibility of Chlamydia trachomatis to trovafloxacin

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. B, 1997, Pages 63-65

  Jones, R B ^a,c   Van Der Pol, B ^a   Johnson, R B ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c EM 435 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ERYTHROMYCIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; NONHUMAN; STRAIN DIFFERENCE; TISSUE CULTURE;

EID: 0030857309     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_2.63     Document Type: Article

References (15)

1. Gates, W., Rolfs, R. T. & Aral, S. O. (1990). Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiologic Reviews 12, 199-220.
2. Martin, D. H. (1990). Chlamydial infections. Medical Clinics of North America 74, 1367-87.
3. Paavonen, J. (1992). Genital Chlamydia trachomatis infections in the female. Journal of Infection 25, Suppl. 1, 39-45.
4. Oriel, D. (1982). Infections of the male genital tract. In Chlamydial Infections, Vol. 2 (Mårdh, P.-A., Holmes, K. K., Oriel, J. D., Piot, P. ̊ Schachter, J., Eds), pp. 93-106. Elsevier Biomedical Press, Amsterdam.
5. Bowie, W. R. (1990). Approach to men with urethritis and urologie complications of sexually transmitted diseases. Medical Clinics of North America 74, 1543-57.
6. Alexander, E. R. & Harrison, H. R. (1983). Role of Chlamydia trachomatis in perinatal infection. Reviews of Infectious Diseases 5, 713-9.
7. Harrison, H. R. & Alexander, E. R. (1990). Chlamydial infections in infants and children. In Sexually Transmitted Diseases, 2nd edn (Holmes, K. K., Mårdh, P.-A., Sparling, P. F. & Wiesner, P. J., Eds), pp. 811-20. McGraw-Hill, New York, NY.
8. Centers for Disease Control. (1993). Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. Morbidity and Mortality Weekly Report 42, Suppl. RR-12, 1-39.
9. Workowski, K. A., Lampe, M. F., Wong, K. G., Watts, M. B. & Stamm, W. E. (1993). Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. Journal of the American Medical Association 270, 2071-5.
10. Katz, B. P., Zwickl, B. W., Caine, V. A. & Jones, R. B. (1992). Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sexually Transmitted Diseases 19, 351-4.
11. Mourad, A., Sweet, R. L., Sugg, N. & Schachter, J. (1980). Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 18, 696-8.
12. Jones, R. B., Van der Pol, B., Martin, D. H. & Shepard, M. K. (1990). Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. Journal of Infectious Diseases 162, 1309-15.
13. Newhall, W. J., Terho, P., Wilde, C. E., Batteiger, B. E. & Jones, R. B. (1986). Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies. Journal of Clinical Microbiology 23, 333-8.
14. van der Pol, B. J. & Jones, R. B. (1992). Comparison of immunotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining and radioimmunoassay. Journal of Clinical Microbiology 30, 1014-15.
15. Centers for Disease Control. (1993). 1993 Sexually transmitted diseases treatment guidelines. Morbidity and Mortality Weekly Report 42, Suppl. RR-14, 1-56.